Sun-Q is the founder and Chairman of MiCo Group. MiCo Group is a diversified industrial group headquartered in South Korea. MiCo Group is engaged in semiconductor, energy and healthcare/ biotech sectors in many countries globally.
Ronan O’CaoimhChief Executive Officer
Ronan co-founded Trinity Biotech in June 1992 and acted as Chief Financial Officer until March 1994 when he became Chief Executive Officer. He was also elected Chairman in May 1995. In November 2007, it was decided to separate the role of Chief Executive Officer and Chairman and Ronan assumed the role of Executive Chairman. In October 2008, following the resignation of the Chief Executive Officer, Ronan resumed the role of Chief Executive Officer and Chairman. In May 2022 Ronan stepped down as Chairman of Trinity Biotech. Prior to joining Trinity Biotech, Ronan was Managing Director of Noctech Limited, an Irish diagnostics company. Ronan was Finance Director of Noctech Limited from 1988 until January 1991 when he became Managing Director. Ronan holds a Bachelor of Commerce degree from University College Dublin.
John GillardChief Financial Officer & Executive Director
John joined Trinity Biotech in November 2020 as Chief Financial Officer, Secretary to the Board of Directors and was appointed to the Board as Executive Director. John is both a Chartered Accountant and Chartered Tax Advisor, having trained at PWC. Prior to joining Trinity Biotech, John held a number of senior financial roles including at Alphabet Inc./Google and at ION Investment Group. John holds a Bachelor of Commerce degree from the National University of Ireland Galway and a Masters degree in Accounting from University College Dublin.
Jim WalshExecutive Director
Jim, PhD, Executive Director, initially joined Trinity Biotech in October 1995 as Chief Operations Officer. Jim resigned from the role of Chief Operations Officer in 2007 to become a Non- Executive Director of the Company. In October, 2010 Jim rejoined the company as Chief Scientific Officer. Jim transferred from this position in 2015 and focuses on Business Development activities. Prior to joining Trinity Biotech, Jim was Managing Director of Cambridge Diagnostics Ireland Limited (“CDIL”). He was employed with CDIL since 1987. Before joining CDIL he worked with Fleming GmbH as Research & Development Manager. Jim holds a PhD degree in Chemistry from University College Galway.
Aris KekedjianNon Executive Director
Aris is a strategic senior executive with broad-based success across industrial and financial businesses and a record of accomplishment in platform leadership, business development, finance, mergers/acquisitions, IPOs, capital markets and global growth. A globally experienced dealmaker, Aris spent 30 years in GE in several senior roles, including 5 years as GE’s Chief Investment Officer. Most recently, Aris was CEO of Icahn Enterprises.
Michael Sung Soo KimNon Executive Director
Michael has a wealth of financial experience having spent the last three decades within international finance across areas such as Asset Management, Real Estate Investments, Robo-Advisory and Wealth Management and has held several senior executive positions include CEO of Hyundai Securities Asia.